欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IE/V/0778/002
药品名称Clavusan 250 mg + 62.5 mg tablets for dogs and cats
活性成分
    • amoxicillin trihydrate 250.0 mg
    • clavulanic acid 62.5 mg
剂型Tablet
上市许可持有人Alfasan Nederland B.V, Kuipersweg 9, 3449 JA Woerden, Netherlands
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • Latvia (LV)
    • Estonia (EE)
    • Denmark (DK)
    • Hungary (HU)
    • Luxembourg (LU)
    • Iceland (IS)
    • Bulgaria (BG)
    • France (FR)
    • Germany (DE)
    • Sweden (SE)
    • Cyprus (CY)
    • Norway (NO)
    • Belgium (BE)
      Clavusan 250 mg + 62,5 mg
    • Finland (FI)
    • United Kingdom (Northern Ireland) (XI)
    • Czechia (CZ)
    • Netherlands (NL)
    • Romania (RO)
    • Austria (AT)
    • Slovakia (SK)
    • Spain (ES)
    • Slovenia (SI)
    • Portugal (PT)
    • Croatia (HR)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
许可日期2023/02/08
最近更新日期2024/07/10
药物ATC编码
    • QJ01CR02 amoxicillin and beta-lactamase inhibitor
申请类型
  • TypeLevel1：non-food
  • TypeLevel2：Pharmaceutical
  • TypeLevel3：Other Generic application Art 13.3 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase